Full details of fusion biopsy technique:
[ Ссылка ]
A new research study at UCLA aims to re-define prostate cancer significance through clinical validation of a tool which allows 3D visualization and tracking of the prostate. By fusing multi-parametric MRI (T2-weighted, diffusion-weighted imaging, dynamic contrast enhancement) with real-time ultrasound, suspicious areas seen on the MRI can be tracked and targeted during prostate biopsy. This research aims to improve currently available methods of cancer diagnosis.
Investigators:
Leonard Marks, M.D. (Urology, [ Ссылка ])
Daniel Margolis, M.D. (Radiology, [ Ссылка ])
Jiaoti Huang, M.D., Ph.D. (Pathology, [ Ссылка ]).
